396 related articles for article (PubMed ID: 29157179)
41. Comparison of the LIAISON®XL and ARCHITECT IgG, IgM, and IgG avidity assays for the diagnosis of Toxoplasma, cytomegalovirus, and rubella virus infections.
Genco F; Sarasini A; Parea M; Prestia M; Scudeller L; Meroni V
New Microbiol; 2019 Apr; 42(2):88-93. PubMed ID: 30994178
[TBL] [Abstract][Full Text] [Related]
42. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
43. TORCH Antibodies Among Pregnant Women and Their Newborns Receiving Care at Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Saajan AM; Nyindo M; Gidabayda JG; Abdallah MS; Jaffer SH; Mukhtar AG; Khatibu TM; Philemon R; Kinabo GD; Mmbaga BT
East Afr Health Res J; 2017; 1(2):95-104. PubMed ID: 34308164
[TBL] [Abstract][Full Text] [Related]
44. Rubella and cytomegalovirus (CMV) infections: laboratory aspects of investigation of antenatal, congenital, persistent, and subclinical infections.
Hossain A; Bakir TM
J Trop Pediatr; 1989 Oct; 35(5):225-9. PubMed ID: 2555534
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
46. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
Silver RM; Pierangeli SS; Edwin SS; Umar F; Harris EN; Scott JR; Branch DW
Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
[TBL] [Abstract][Full Text] [Related]
47. Immune status in congenital infections by TORCH agents in pregnant Thais.
Taechowisan T; Sutthent R; Louisirirotchanakul S; Puthavathana P; Wasi C
Asian Pac J Allergy Immunol; 1997 Jun; 15(2):93-7. PubMed ID: 9346273
[TBL] [Abstract][Full Text] [Related]
48. [Antiphospholipid antibodies in practice].
Miyara M; Diemert MC; Amoura Z; Musset L
Rev Med Interne; 2012 Apr; 33(4):176-80. PubMed ID: 22100197
[TBL] [Abstract][Full Text] [Related]
49. [Investigation on TORCH infections for pregnant women and neonates in Yan'an City].
Zhang QQ; Cheng JZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):386, 392. PubMed ID: 23236780
[TBL] [Abstract][Full Text] [Related]
50. Utility of routine urine CMV PCR and total serum IgM testing of small for gestational age infants: a single center review.
Espiritu MM; Bailey S; Wachtel EV; Mally PV
J Perinat Med; 2018 Jan; 46(1):81-86. PubMed ID: 28803228
[TBL] [Abstract][Full Text] [Related]
51. Antibody profiles for the diagnosis of antiphospholipid syndrome.
Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
[TBL] [Abstract][Full Text] [Related]
52. Seroepidemiology Study of Cytomegalovirus and Rubella among Pregnant Women at St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Yeshwondm M; Balkachew N; Delayehu B; Mekonen G
Ethiop J Health Sci; 2016 Sep; 26(5):427-438. PubMed ID: 28446848
[TBL] [Abstract][Full Text] [Related]
53. IgG avidity assay: a tool for excluding acute toxoplasmosis in prolonged IgM titer sera from pregnant women.
Emelia O; Rahana AR; Mohamad Firdaus A; Cheng HS; Nursyairah MS; Fatinah AS; Azmawati MN; Siti NA; Aisah MY
Trop Biomed; 2014 Dec; 31(4):633-40. PubMed ID: 25776588
[TBL] [Abstract][Full Text] [Related]
54. [TORCH infections in mothers as a cause of neonatal morbidity].
Mladina N; Mehikić G; Pasić A
Med Arh; 2000; 54(5-6):273-6. PubMed ID: 11219902
[TBL] [Abstract][Full Text] [Related]
55. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland.
Morris A; Croxson M
N Z Med J; 2004 Feb; 117(1189):U770. PubMed ID: 15014559
[TBL] [Abstract][Full Text] [Related]
56. TORCH screening in polyhydramnios: an observational study.
Fayyaz H; Rafi J
J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1069-72. PubMed ID: 21923307
[TBL] [Abstract][Full Text] [Related]
57. TORCH testing in non-familial paediatric cataract.
Mc Loone E; Joyce N; Coyle P
Eye (Lond); 2016 Sep; 30(9):1275-6. PubMed ID: 27494085
[No Abstract] [Full Text] [Related]
58. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
Ofer-Shiber S; Molad Y
Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
[TBL] [Abstract][Full Text] [Related]
59. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.
Zhang L; Wang X; Liu M; Feng G; Zeng Y; Wang R; Xie Z
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010861. PubMed ID: 36240247
[TBL] [Abstract][Full Text] [Related]
60. Infectious immune status in an obstetric population of Pakistani immigrants in Norway.
Bjerke SE; Vangen S; Holter E; Stray-Pedersen B
Scand J Public Health; 2011 Jul; 39(5):464-70. PubMed ID: 21339369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
